THE MARKET
Alzheimer’s Disease is the leading cause of dementia, accounting for up to 80% of cases.
Over 7 million Americans are living with Alzheimer’s. This number could grow to 13.8 million by 2060.
Worldwide, more than 50 million people are affected, and this number will almost triple to 152 million in 2050 if no effective preventive or therapeutic solutions are found.
Alzheimer’s is a leading cause of death in the U.S., ranking 7th in 2024. The actual death toll may be much higher than recorded.
Deaths attributed to Alzheimer’s Disease rose more than 145% in the last 20 years.
Sources: Alzheimer’s Association and National Library of Medicine
Nearly 12 million Americans provide unpaid care for a family member or friend with dementia, a contribution to the nation valued at more than $413 billion.
In 2025 for health care, long‐term care and hospice services for people with dementia are estimated to be $384 billion. By 2050 these costs could rise to nearly 1 trillion.
Early detection is crucial and could save caregivers and healthcare systems approximately $7 trillion in medical and long-term care costs for individuals.
Sources: Alzheimer’s Association
More than 9 in 10 Americans would want a simple medical test if it were available. – 91% would want testing before symptoms appear.
Four in 5 Americans (80%) indicated they would ask for a simple medical test to detect Alzheimer’s rather than waiting for a doctor to suggest it.
The global Alzheimer’s disease diagnostics market size was estimated at USD 8.3 billion in 2024 and is expected to grow to 15.5 billion at a CAGR of 11.03% from 2025 to 2030.
Sources: Alzheimer’s Association
